MDS Virtual Congress 2021 (Videos)

MDS Virtual Congress 2021: A Global Gathering of Parkinson’s and Movement Disorder Experts

The International Congress of Parkinson’s Disease and Movement Disorders, convened virtually from September 17-22, 2021, brought together a remarkable cohort of healthcare professionals, researchers, and industry leaders from around the globe. The event served as a pivotal platform for sharing cutting-edge knowledge, fostering collaborations, and advancing the understanding and treatment of Parkinson’s and movement disorders.

Meeting by the Numbers: A Testimony to the Event’s Reach

The MDS Virtual Congress 2021 witnessed an overwhelming turnout, with over 13,000 attendees hailing from an impressive 143 countries. This global representation reflected the Congress’s commitment to promoting international collaboration and disseminating knowledge on a worldwide scale.

The Scientific Program featured an esteemed faculty of 221 experts who shared their insights on the latest advancements in research, diagnostics, and therapeutics. These luminaries presented a total of 1,320 scientific abstracts, showcasing the breadth and depth of current knowledge in the field. Among these, 56 abstracts were recognized as Top Abstracts, further underscoring the exceptional caliber of the research findings presented.

In addition to the scientific abstracts, the Congress hosted 11 late-breaking abstracts that highlighted groundbreaking discoveries and emerging trends in the field. These abstracts sparked lively discussions and provided attendees with the freshest updates in the rapidly evolving landscape of Parkinson’s and movement disorders.

The exhibition hall hosted 49 virtual exhibits, representing a diverse array of 30 companies and organizations. These exhibits showcased innovative technologies, therapies, and services, offering attendees the opportunity to connect with industry leaders and learn about the latest advancements in patient care. Notably, 13 nonprofit exhibitors also participated, highlighting their unwavering dedication to supporting research and providing essential resources to the Parkinson’s and movement disorder community.